Embolization and serum lysozyme activity in renal cancer

Neoplasma

Volumn 45, Issue 3, 1998, Pages 148-150

  Mantur, M ^a   Matowicka Karna, J ^a   Darewicz, B ^a   Kemona, H ^a   Dymicka Piekarska, V ^a   Prokopowjcz, J ^a   Darewicz, J ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Cancer disease; Embolization; Lysozyme activity

Indexed keywords

LYSOZYME;

ADULT; ARTICLE; ARTIFICIAL EMBOLISM; CANCER IMMUNOLOGY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; IMMUNOGENICITY; IMMUNOREACTIVITY; KIDNEY CARCINOMA; MALE; NEUTROPHIL;

EID: 0031812247     PISSN: 00282685     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. ALBELDA, S.M.: Biology of disease. Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab.Invest., 68, 1993, 4-7.
2. ANDERSON, D.C.; The role of phagocytic cells in host defense and inflammatory disease. Nutrition, 6, 1990, 5-15.
3. CYLWIK, B., DAREWICZ, J., KARASEWICZ, B.: Morphometric investigations of dog kidney after renal artery embolization with spongostan. Int. Urol. Nephrol., 17, 1985, 109-114.
4. HARRISON, J.F., BARNES, A.D.: The urinary excretion of lysozyme in dogs. Clin. Sci., 38, 1970, 533-540.
5. KENDZIOREK, A., TOMASZEWSKA, Z.: Role of cytokines in inflammatory reactions. Medycyna 2 000, 20, 1994, 20-25.
6. MANI, S., TOOD, M.B., KOTZ, K., POO, W.J.: Prognostic factors for survival in patients with metastatic renal cancer treated with biological response modifiers. J. Urol., 154, 1995, 35-39.
7. MUSCAT, J., HOFFMAN, D., WYNDER, E.L.: The epidemiology of renal cell carcinoma. Cancer, 75, 1995, 2552-2564.
8. PROKOPOWICZ, J., KEMONA, H., WYSOCKA, J., KILUK, S.: Serum lysozyme activity in patients with lung carcinoma subjected to radiotherapy. Neoplasma, 32, 1985, 605-611.
9. PRUZAŃSKI, W., RANADIVE, N.S., SAITO, S.: Modulation of phagocytosis and intracellular bactericidal activity of polymorphonuclear and mononuclear cells by cationic proteins from human granulocytes. Inflammation, 4, 1984, 445-457.
10. SAVA, G., BENETTI, A., CESCHIA, V., PACOR, S.: Lysozyme and cancer: Role of exogenous lysozyme as anticancer agent. Review. Anticancer Res., 9, 1989, 583-592.
11. SMOLELIS, A.N., HARTSELL S.E.: The determination of lysozyme. J. Bacteriol., 58, 1949, 731-737.
12. WYSOCKA, J., KEMONA, H., JAWORSKI, S., MATOWICKA-KARNA, J., LOTOCKI, W., MANTUR, M., BIAŁOWAŞ, D.: Activity of lysozyme in blood serum of pregnant women in normal and in EPH-gestosis complicated pregnancy, Diagn. Lab., 27, 1991, 24-29.
13. ZEMAN, K., KANTORSKI, J.: Oxygen-independent microbiocidal systems of neutrophils. Postepy. Biol. Kom., 17, 4, 1990, 379-387.
14. ZEMAN, K.: The modern aspects of neutrophils in the inflammation, II. Interrelationships between neutrophils and immune system. Pol. J. Immunol., 18, 1993, 23-44.